Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Current and promising applications of Hf(IV)-based MOFs in cancer therapy
Xuelin
Chen
ab,
Minmin
Li
b,
Mingzi
Lin
b,
Chengyu
Lu
b,
Abhinav
Kumar
*c,
Ying
Pan
*ab,
Jianqiang
Liu
*abd and
Yanqiong
Peng
*a
aThe First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523808, China. E-mail: sunshine_may1@163.com
bGuangdong Provincial Key Laboratory of Research and Development of Natural Drugs, and School of Pharmacy, Guangdong Medical University, Guangdong Medical University Key Laboratory of Research and Development of New Medical Materials, Dongguan, 523808, China. E-mail: panying@gdmu.edu.cn; jianqiangliu2010@126.com
cDepartment of Chemistry, Faculty of Science, University of Lucknow, Lucknow 226 007, India. E-mail: abhinavmarshal@gmail.com
dAffiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
First published on 31st July 2023
Abstract
Correction for ‘Current and promising applications of Hf(IV)-based MOFs in cancer therapy’ by Xuelin Chen et al., J. Mater. Chem. B, 2023, 11, 5693–5714, https://doi.org/10.1039/D3TB00267E.
The authors regret an error in the title. The corrected title is provided below:
Current and promising applications of Hf(IV)-based MOFs in cancer therapy
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |